Slideshow
Author(s):
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
Valbenazine Safe and Effective for Long-Term Treatment of Tardive Dyskinesia in Elders
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
This Week on NeurologyLive® — April 28, 2025
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose
GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk